Combination drug therapy for childhood brain tumors shows promise in laboratory models
In experiments with human cells and mice, researchers report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.
from Latest Science News -- ScienceDaily https://ift.tt/39InHVY
from Latest Science News -- ScienceDaily https://ift.tt/39InHVY
Related Posts :
Mountain gorillas are good neighbors - up to a point- Tailoring 2D materials to improve electronic and optical devices
- Secret surfing life of remoras hitchhiking on blue whales
- Average body temperature among healthy adults declined over the past two decades
- Photovoltaics industry can help meet Paris agreement targets
0 Response to "Combination drug therapy for childhood brain tumors shows promise in laboratory models"
Post a Comment